| 摘要 |
The invention generally relates to thienopyridinone 5-HT4 receptor modulators, and in particular the use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with serotonin action, such as in treating Alzheimer's disease, cognition disorders, depression, and anxiety. |
| 申请人 |
EPIX PHARMACEUTICALS, INC.;DHANOA, DALE, S.;BECKER, OREN, M.;NOIMAN, SILVIA;MOHANTY, PRADYUMNA;CHEN, DONGLI;LOBERA, MERCEDES;WU, LAURENCE;MARANTZ, YAEL;INBAL, BOAZ;HEIFETZ, ALEXANDER;BAR-HAIM, SHAY;SHACHAM, SHARON |
发明人 |
DHANOA, DALE, S.;BECKER, OREN, M.;NOIMAN, SILVIA;MOHANTY, PRADYUMNA;CHEN, DONGLI;LOBERA, MERCEDES;WU, LAURENCE;MARANTZ, YAEL;INBAL, BOAZ;HEIFETZ, ALEXANDER;BAR-HAIM, SHAY;SHACHAM, SHARON |
